{"DataElement":{"publicId":"2837849","version":"1","preferredName":"USMCI Patient 8214 Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of inclusion clinical trial eligibility criteria for central pathology review in USMCI 8214 protocol related to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI, USMCI which is tri-service program whose goal is to initiate, develop, coordinate and enhance multi-institutional cancer research, education and care within the military system.","longName":"USMCI_P_8214_CT_C_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2837825","version":"1","preferredName":"United States Military Cancer Institute Patient Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information related to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI, USMCI which is tri-service program whose goal is to initiate, develop, coordinate and enhance multi-institutional cancer research, education and care within the military system.","longName":"USMCI_PT_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2837823","version":"1","preferredName":"Military Patient","preferredDefinition":"The armed forces of a country.:A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","longName":"C68638:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Military","conceptCode":"C68638","definition":"The armed forces of a country.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62817FE6-FAF7-68E4-E040-BB89AD431A37","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518229","version":"1","preferredName":"Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"The addition of somebody or something to, or the presence of somebody or something in, a group or mixture, particularly, a passive, usually temporary, product of cell activity within the cytoplasm or nucleus.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25532:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08D4-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62817FE6-FB05-68E4-E040-BB89AD431A37","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2837837","version":"1","preferredName":"USMCI 8214 Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of inclusion clinical trial eligibility criteria for central pathology review in USMCI 8214 protocol.","longName":"USMCI8214_CTEC_CP_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"White blood cell count > 4000/mm3, ANC > 1200/mm3, Platelet count > 150,000/mm3, INR <= 1.5, Serum bilirubin  <= 1.5 mg/dl, Alkaine phosphatase < 2.5 times ULN, AST < 1.5 times ULN, Serum creatinine within normal limits","valueDescription":"White blood cell count > 4000/mm3, ANC > 1200/mm3, Platelet count > 150,000/mm3, INR <= 1.5, Serum bilirubin  <= 1.5 mg/dl, Alkaine phosphatase < 2.5 times ULN, AST < 1.5 times ULN, Serum creatinine within normal limits","ValueMeaning":{"publicId":"2837839","version":"1","preferredName":"White blood cell count > 4000/mm3, ANC > 1200/mm3, Platelet count > 150,000/mm3, INR <= 1.5, Serum bilirubin  <= 1.5 mg/dl, Alkaine phosphatase < 2.5 times ULN, AST < 1.5 times ULN, Serum creatinine within normal limits","longName":"2837839","preferredDefinition":"Patient meets the following laboratory criteria: White blood cell count > 4000/mm3, AND Absolute neutrophil count (ANC) > 1200/mm3, AND Platelet count > 150,000/mm3, AND INR <= 1.5, AND Serum bilirubin <= 1.5 mg/dl (patients with total bilirubin > 1.5 mg/dL has known Gilbert's syndrome), AND Alkaine phosphatase < 2.5 times upper limit of normal, AND AST < 1.5 times upper limit of normal, AND Serum creatinine within normal limits","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CBB0-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62BBAD94-1303-DDCB-E040-BB89AD430FBD","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-12","modifiedBy":"ONEDATA","dateModified":"2009-02-12","deletedIndicator":"No"},{"value":"Patients with cardiopulmonary function satisfactory to undergo operation evident by:No history if severe CHF or pulmonary disease,No history of acute MI within 6 months of enrollment,Satisfactory function after cardiac testing after revascularization","valueDescription":"Patients with cardiopulmonary function satisfactory to undergo operation evident by:No history if severe CHF or pulmonary disease,No history of acute MI within 6 months of enrollment,Satisfactory function after cardiac testing after revascularization","ValueMeaning":{"publicId":"2837838","version":"1","preferredName":"Patients with cardiopulmonary function satisfactory to undergo operation evident by:No history if severe CHF or pulmonary disease,No history of acute MI within 6 months of enrollment,Satisfactory function after cardiac testing after revascularization","longName":"2837838","preferredDefinition":"Patients with cardiopulmonary function satisfactory to undergo operation evident by:No history if severe CHF or pulmonary disease,No history of acute MI within 6 months of enrollment,Satisfactory function after cardiac testing after revascularization","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CB8D-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CBA6-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patients have not received or only received prior first-line systemic regimens","valueDescription":"Patients have not received or only received prior first-line systemic regimens","ValueMeaning":{"publicId":"2837840","version":"1","preferredName":"Patients have not received or only received prior first-line systemic regimens","longName":"2837840","preferredDefinition":"Patients have not received or only received prior first-line systemic regimens","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CBD3-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CBEC-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Patient has a life expectancy > 6 months","valueDescription":"Patient has a life expectancy > 6 months","ValueMeaning":{"publicId":"2837841","version":"1","preferredName":"Patient has a life expectancy > 6 months","longName":"2837841","preferredDefinition":"Patient has a life expectancy > 6 months","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CBF6-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CC0F-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Performance status of 2 or less","valueDescription":"Performance status of 2 or less","ValueMeaning":{"publicId":"2837842","version":"1","preferredName":"Performance status of 2 or less","longName":"2837842","preferredDefinition":"Performance status of 2 or less","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CC19-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CC32-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"The patient has newly diagnosed, previously untreated, limited and documented peritoneal surface adenocarcinoma (not signet ring cell type) with synchronous or metachnronous documented limiter peritoneal dissemination)","valueDescription":"The patient has newly diagnosed, previously untreated, limited and documented peritoneal surface adenocarcinoma (not signet ring cell type) with synchronous or metachnronous documented limiter peritoneal dissemination)","ValueMeaning":{"publicId":"2837843","version":"1","preferredName":"The patient has newly diagnosed, previously untreated, limited and documented peritoneal surface adenocarcinoma (not signet ring cell type) with synchronous or metachnronous documented limiter peritoneal dissemination)","longName":"2837843","preferredDefinition":"The patient has newly diagnosed, previously untreated, limited and documented peritoneal surface adenocarcinoma (not signet ring cell type) with synchronous or metachnronous documented limiter peritoneal dissemination)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CC3C-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CC55-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"The patient has peritoneal surface malignancy of colonic origin (colon adenocarcinoma)","valueDescription":"The patient has peritoneal surface malignancy of colonic origin (colon adenocarcinoma)","ValueMeaning":{"publicId":"2837844","version":"1","preferredName":"The patient has peritoneal surface malignancy of colonic origin (colon adenocarcinoma)","longName":"2837844","preferredDefinition":"The patient has peritoneal surface malignancy of colonic origin (colon adenocarcinoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CC5F-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CC78-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"},{"value":"Age 18 years of age or older, capable of providing informed consent and willing to return for follow-up","valueDescription":"Age 18 years of age or older, capable of providing informed consent and willing to return for follow-up","ValueMeaning":{"publicId":"2837845","version":"1","preferredName":"Age 18 years of age or older, capable of providing informed consent and willing to return for follow-up","longName":"2837845","preferredDefinition":"Age 18 years of age or older, capable of providing informed consent and willing to return for follow-up","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CC82-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6281EA76-CC9B-C443-E040-BB89AD435389","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281EA76-CB7A-C443-E040-BB89AD435389","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ALAIS","dateModified":"2009-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Inclusion Criteria","type":"Preferred Question Text","description":"Inclusion Criteria","url":null,"context":"CTEP"}],"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6281C75A-48E6-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-09","modifiedBy":"ALAIS","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}